Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
08/2000
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2362077A1 Cyclic amine derivatives and uses thereof
08/09/2000EP1024808A1 Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
08/09/2000EP1024807A1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment
08/09/2000CN1262620A Beta-Alkoxyacrylates against malaria
08/09/2000CN1262618A NF-KB inhibitors containing as active ingredient phenylmethyl benzoquinone
08/09/2000CN1262272A HIV proteinase inhibitor
08/08/2000US6100420 Heterocyclylbenzonitriles
08/08/2000US6100398 Transition metal-catalyzed process for preparing N-aryl amine compounds
08/08/2000US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
08/08/2000US6100263 Controlling animal pests or harmful fungi; 2-methoxyimino-2-(2'-(1?-methyl,1?-(1?'-(6??-(4??'-chlorophenyl) -hexyloxyimino) ,2?',2?'-dimethylpropyl))iminooxymethyl)-phenylacetic acid monomethylamide, for example
08/08/2000CA2185512C Treatment of tinnitus using neuroprotective agents
08/08/2000CA2072575C Anticholinergic agents
08/03/2000WO2000044742A1 Improved sensitizers for use in photodynamic therapy
08/03/2000WO2000044739A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
08/03/2000WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044701A1 Material for light energy storage/light-heat energy conversion
08/03/2000WO2000003975A3 Aryl vinyl ether derivatives and their use as herbicides
08/03/2000DE19904310A1 Verfahren zur Herstellung heterocyclischer Verbindungen Process for the preparation of heterocyclic compounds
08/03/2000DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis
08/03/2000CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/02/2000EP1024140A1 Process for N-alkylation of cyclic cyanoamidines
08/02/2000EP1024134A1 Aminobutanoic acid derivatives
08/02/2000EP1023308A1 Inhibitors of nucleoside metabolism
08/02/2000EP1023294A1 Carbapenem derivatives and a preparation method thereof
08/02/2000EP1023288A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
08/02/2000EP0691953B1 1-amidinophenyl-pyrrolidones/ piperidinones as platelet aggregation inhibitors
08/02/2000EP0642303B1 Substituted 2-arylpyrroles
08/02/2000CN1261883A Novel compounds
08/02/2000CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
08/02/2000CN1261795A Compounds and methods
08/02/2000CN1261688A 照相黄色成色剂 Photographic yellow couplers
08/02/2000CN1261611A Method for preparing deep colour perylene dye
08/02/2000CN1261534A Medicinal composition containing naphthyl compound
08/01/2000US6096774 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, intiators and gas generators
08/01/2000US6096762 Contacting nerve cells with a neurotrophic amount of difluoroamide compound with affinity for an fk-506 binding protein for stimulating neurite grwoth in nerve cells
08/01/2000US6096749 Pyrrolopyrimidine derivatives having pharmacological activity
08/01/2000US6096741 Oxime derivatives, hydrazone derivatives and use thereof
08/01/2000US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents
08/01/2000CA2019335C Phenylalkan (en)oic acids
07/2000
07/27/2000WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043352A1 A method for the synthesis of compounds of formula 1 and derivatives thereof
07/27/2000WO2000023429A3 Stereoselective process for producing cryptophycins
07/27/2000WO2000018358A3 Method of treating hair loss using ketoamides
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses
07/27/2000WO1999063994A9 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
07/27/2000WO1999062881A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
07/27/2000WO1999057098A3 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
07/27/2000DE19833118C2 Verfahren zur Herstellung von orthoalkylierten Benzoesäurederivaten Process for the preparation of benzoic acid derivatives orthoalkylierten
07/27/2000CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359076A1 A method for the synthesis of compounds of formula 1 and derivatives thereof
07/26/2000EP1022029A1 Nootropic agent
07/26/2000EP1021410A1 Prostaglandin agonists and their use to treat bone disorders
07/26/2000EP1021407A1 Synthesis of clasto-lactacystin beta-lactone and analogs thereof
07/26/2000EP1021406A1 Novel anandamide amidase inhibitors as analgesic agents
07/26/2000EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS
07/26/2000EP0796245B1 Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs
07/26/2000CN1261366A Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
07/26/2000CN1054849C Process for producing quaternary glycine nitriles
07/26/2000CN1054843C Method for prepn. of N-methyl pyrrolidone
07/26/2000CN1054842C 1-amidinophenyl-pyrrolidones piperidinones azetinones platelet aggregation inhibitors
07/25/2000US6093820 Reacting an imide with a (substituted)alkoxyalkylsulfonic acid ester to form a n-alkoxyalkyl imide such as methoxymethyl ethosuximide; administering as anticonvulsant, antianxiety agent and muscle relaxant
07/25/2000US6093748 Applying to an area of skin from which reduced hair growth is desired a dermatologically acceptable composition containing a non-steroidal suppressor of angiogenesis
07/20/2000WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response
07/20/2000WO2000042059A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
07/20/2000WO2000042010A1 Contrast media for angiography
07/20/2000WO2000042009A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea
07/20/2000WO2000042007A1 Alfa-sulfenimino acid derivatives
07/20/2000WO2000041698A1 φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
07/20/2000WO2000041505A2 Anthranilic acid derivatives
07/20/2000WO2000014064A3 Gaba uptake inhibitors having a pyrrolidine structure
07/20/2000WO1999064048A9 Inhibitors of hiv reverse transcriptase
07/20/2000CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response
07/20/2000CA2360560A1 Contrast media for angiography
07/20/2000CA2359244A1 .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
07/20/2000CA2355792A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
07/20/2000CA2349180A1 Anthranilic acid derivatives
07/19/2000EP1020496A1 Process for the preparation of highly chromatic perylene pigments
07/19/2000EP1020459A1 Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
07/19/2000EP1020442A1 Novel diamino compounds, polyamic acid, polyimide, liquid-crystal alignment film made from film of the polyimide, and liquid-crystal display element containing the alignment film
07/19/2000EP1020440A1 Intermediates useful in producing carbapenem and process for the stereoselective production of the same
07/19/2000EP1020439A1 Cetp activity inhibitors
07/19/2000EP1020179A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
07/19/2000EP1019411A1 Process for synthesizing carbapenem side chain intermediates
07/19/2000EP1019371A2 Dimaleinimido-substituted dihydroxyalkanes which can be used as crosslinking reagents and process for their preparation
07/19/2000EP1019370A1 Ace-inhibitor nitric salts
07/19/2000EP1019367A1 Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use
07/19/2000EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019358A1 Novel compounds, their use and preparation
07/19/2000EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
07/19/2000CN1260798A Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha 1-blocking action
07/19/2000CN1260791A 3-benzylpiperidine
07/19/2000CN1260780A Ace-inhibitor nitric salts
07/19/2000CN1260345A Hydrazide compound, its preparing method and medicine compositions thereof
07/19/2000CN1054603C Tri-substituted phenyl derivatives and medicinal composition containing same
07/19/2000CN1054594C Inhibition of unsaturated monomers with 7-aryl quinone methides